Clinical Trial Update: Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 study on using molecular risk assessment to guide treatment decisions for patients with Non-Hodgkin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED